---
notetoolbar: Study
tags:
  - HEMAascpi
---


# HEMATOPOEISIS
## Erythropoeisis
?
- Key regulatory factors for Erythropoeisis
	- <mark class="red">Erythropoeitin</mark>
	- <mark class="red">GM-CSF</mark>
- (18 - 21 days) BFU → mature RBC

![[Pasted image 20240429145333.png]]::<mark class="red">PROnormoblast (Rubriblast)</mark>
![[Pasted image 20240429145342.png]]::<mark class="red">BASOPHILIC Normoblast (Prorubricyte)</mark>
![[Pasted image 20240429145358.png]]::<mark class="red">POLYCHROMATIC Normoblast (Rubricyte)</mark>
![[Pasted image 20240429145414.png]]::<mark class="red">ORTHOCHROMIC Normoblast (Metarubricyte)</mark>
![[Pasted image 20240429145421.png]]::<mark class="red">POLYCHROMATIC Erythrocyte (Reticulocyte)</mark>
![[Pasted image 20240429145432.png]]::<mark class="red">Erythrocyte</mark>

- Size: **12 – 25 um**<br>- NC Ratio: **8:1**<br>- Nucleus: **fine and uniform chromatin pattern** with **prominent nuclear membrane**; one or more nucleoli are present<br>- Cytoplasm: **heterogenous** quality and is moderate in amount and basophilia, **no granules** are present.<br><br>- GLOBIN production BEGINS::<mark class="red">PROnormoblast (Rubriblast)</mark>
- Size: **12 – 17 um**<br>- NC Ratio: **6:1**<br>- Nucleus: **Centrally** located with **coarser chromatin** pattern that may be **partially clumped**; **distinct pink-staining parachromatin**; **nucleolus (+)** not visible<br>- Cytoplasm: **Intensely basophilic** due to abundance of RNA<br><br>- Hemoglobin production STARTS::<mark class="red">BASOPHILIC Normoblast (Prorubricyte)</mark>
- Size: **12 – 15 um**<br>- NC Ratio: **4:1**<br>- Nucleus: **More condensed** and occupies about half of the cell area; **condensed coarse chromatin** with a **more distinct parachromatin**; stains intensely<br>- Cytoplasm: **blue-gray to pink-gray** (polychromatophilic/ polychromasia)<br><br>- Hemoglobin becomes evident<br>- LAST stage capable of MITOSIS::<mark class="red">POLYCHROMATIC Normoblast (Rubricyte)</mark>
- Size: **8 – 12 um**<br>- NC Ratio: **1:2**<br>- Nucleus: **pyknotic** (a small, homogenous blue-black mass with no structure)<br>- Cytoplasm: **abundant hemoglobin** and **fewer polyribosomes** and pinkish pale violet- blue gray (slightly polychromatophilic)<br><br>- LAST NUCLEATED phase::<mark class="red">ORTHOCHROMIC Normoblast (Metarubricyte)</mark>
- Size: **7 – 20 um**<br>- Nucleus: NONE<br>- Cytoplasm: **pink to slight pinkish gray** (polychromasia) as a result of the retention of RNA<br><br>- 1st stage to be released in the PERIPHERAL CIRCULATION (stays only for approx. 1-2 days)::<mark class="red">POLYCHROMATIC Erythrocyte (Reticulocyte)</mark>
- Size: **6 – 8 um**<br>- Nucleus: NONE<br>- Cytoplasm: **pink to reddish pink**::<mark class="red">Erythrocyte</mark>

## Granulopoeisis
?
- Key regulators
	- <mark class="red">GM-CSF</mark>
	- <mark class="red">G-CSF</mark>
	- IL-<mark class="red">5</mark> (Eosinophils)
	- IL-<mark class="red">3</mark>, IL-<mark class="red">4</mark> (Basophils)
![[Hema (ASCPi)#^kfzagh]]

![[Pasted image 20240429145451.png]]::<mark class="red">MyeloBLAST</mark>
![[Pasted image 20240429145459.png]]::<mark class="red">Promyelocyte</mark>
![[Pasted image 20240429145508.png]]::<mark class="red">Myelocyte</mark>
![[Pasted image 20240429145516.png]]::<mark class="red">Metamyelocyte</mark>
![[Pasted image 20240429145533.png]]::<mark class="red">Band/Stab</mark>
![[Pasted image 20240429145541.png]]::<mark class="red">PMN Neutrophil/Segmenter</mark>

**CD<mark class="red">34</mark>, ↑ CD<mark class="red">55</mark>**::<mark class="red">MyeloBLAST</mark>
**(-)CD<mark class="red">34</mark>, ↓ CD<mark class="red">55</mark>**<br><br>**(+) CD<mark class="red">66b</mark>**::<mark class="red">Promyelocyte</mark>
Morphologically recognizable stage (differentiate the type of granulocyte to become)<br>- Last stage capable of MITOSIS<br><br>**(-)CD<mark class="red">45r</mark>, CD<mark class="red">117</mark>**<br>**(+)CD<mark class="red">11</mark>, CD<mark class="red">24</mark>, Cd<mark class="red">66a</mark>**::<mark class="red">Myelocyte</mark>
Juvenile cell<br><br>**(+)CD<mark class="red">16</mark>**::<mark class="red">Metamyelocyte</mark>
1st stage normally found in the PERIPHERAL CIRCULATION<br><br>consider band/stab as neutrophil in counting<br><br>**(-)CD<mark class="red">18</mark>, CD<mark class="red">49d</mark>, CD<mark class="red">64</mark>**<br>**(+)CD<mark class="red">35</mark>, CD<mark class="red">87</mark>**::<mark class="red">Band/Stab</mark>
**(+)CD<mark class="red">10</mark>, CD<mark class="red">14</mark>**::<mark class="red">PMN Neutrophil/Segmenter</mark>



## MORPHOLOGIC CHANGES THAT OCCUR DURING NORMAL BLOOD CELL MATURATION
?
![[Hema (ASCPi)#^xkzf1s]]

# HEMOGLOBIN
?
![[Pasted image 20240508151950.png]]

## <mark class="red">HEME</mark> Synthesis
?
**mitochondria**, **cytoplasm/cytosol**

- <mark class="red">4</mark>: iron atoms in each hemoglobin molecule<br>- <mark class="red">Fe2+ (Ferrous)</mark>: state of iron::<mark class="red">Iron absorption and transport</mark>
- **Final product** in hemoglobin synthesis::<mark class="red">Protoporphyrin</mark> formation
- **Transferrin receptors in the pronormoblast bind iron** for incorporation during erythropoiesis<br><br>- <mark class="red">Ferrochelatase</mark> (important enzyme)::<mark class="red">Insertion of iron</mark>

## <mark class="red">GLOBIN</mark> Synthesis
?
**ribosomes**


- Chromosome <mark class="red">11</mark>: **1 gene each** for production of **epsilon**, **beta**, **gamma** and **delta** chains<br>- Chromosome <mark class="red">16</mark>: **3 genes** for the production of **alpha (2)** and **zeta (1) chains**.::<mark class="red">Genetic control</mark>
- **Alpha** chains have <mark class="red">141</mark> amino acids<br>- **Beta** chains have <mark class="red">146</mark> amino acids::<mark class="red">Globin chain structure</mark>



## Molecular Structure of Normal Hemoglobins
?
![[Hema (ASCPi)#^n81rhv]]



## Abnormal Hemoglobin Derivatives

Affinity of oxygen is **200x higher** than normal<br><br>**cherry-red** blood::<mark class="red">Carboxyhemoglobin</mark>
Iron in **ferRIC state (Fe3+)**: individuals are **CYANOTIC**<br><br>inherited condition (<mark class="red">Hgb M</mark>)<br>**brownish** blood::<mark class="red">Methemoglobin</mark>
**toxic** to humans, affinity to oxygen is **100x more** than normal<br><br>IRreversible<br>NOT MEASURED in the Cyanmethemoglobin method<br>**mauve-lavender** blood<br>**GREEN PIGMENT**::<mark class="red">Sulfhemoglobin</mark>



## Oxyhemoglobin Dissociation Curve
?
- N: <mark class="red">Sigmoid Curve</mark>
- Y axis (O2 saturation) = amt. of oxygen attached to HEMOGLOBIN
- X axis (O2 partial pressure) = amt. of oxygen in the BLOOD
- p50 = <mark class="red">26.6 mmHg</mark>; value that saturations 50% of Hemoglobin
![[Pasted image 20240429151253.png]]

<mark class="red">↑ O2 affinity to Hgb</mark><br><mark class="red">↓ O2 deliver to the tissues</mark><br><br><mark class="red">↓ H+, ↑pH</mark><br><mark class="red">↓ 2,3-DPG, CO2</mark><br>abnormal Hgb w/ HIGH O2 affinity (<mark class="red">Hgb F</mark>, <mark class="red">Carboxyhemoglobin</mark>, <mark class="red">Sulfhemoglobin</mark>)::<mark class="red">LEFT</mark> Shift (B)
<mark class="red">↓ O2 affinity to Hgb</mark><br><mark class="red">↑ O2 delivery to the tissues</mark><br><br><mark class="red">↑ H+, ↓ pH</mark><br><mark class="red">↑ 2,3-DPG, CO2</mark><br><mark class="red">exercise, high altitude</mark><br>::<mark class="red">RIGHT</mark> Shift (C)

## Hemoglobin Electrophoresis


![[Pasted image 20240429151330.png]]<br><br>pH = <mark class="red">8.4</mark>::<mark class="red">CELLULOSE ACETATE</mark>
![[Pasted image 20240429151340.png]]<br><br>pH = <mark class="red">6.0 - 6.2</mark>::<mark class="red">ACID CITRATE</mark>

# ERYTHROCYTE DESTRUCTION

- Lysis of RBCs by **macrophages** in the <mark class="red">spleen</mark> and sometimes <mark class="red">liver</mark> or <mark class="red">bone marrow</mark><br>- Represents **majority (90%)** of normal erythrocyte destruction.<br><br>KEY FEATURES<br>- <mark class="red">Microspherocytes</mark><br>- ↑ LD<br>- N to ↓ Haptoglobin<br>- ↑ B1<br>- ↑ urine & fecal urobilinogen<br><br>- Ig<mark class="red">G</mark>::<mark class="red">EXTRA</mark>vascular Hemolysis
- Lysis of RBCs within the <mark class="red">circulation</mark><br>- Represents only about **10%** of normal erythrocyte destruction<br><br>KEY FEATURES<br>- <mark class="red">Schistocytes</mark><br>- ↑ LD<br>- ↓ Haptoglobin<br>- ↑ Free (plasma) hemoglobin<br>- ↑ urine hemoglobin<br>- ↑ B1 (not frequent, usually EXTRAvascular)<br>- HemosiderinURIA<br><br>- HemoglobinURIA occurs when HAPTOGLOBIN is DEPLETED<br>- Ig<mark class="red">M</mark>::<mark class="red">INTRA</mark>vascular Hemolysis



# DISEASES OF ERYTHROCYTES

## Classification of Anemias
?
> [!NOTE] ANEMIA
> - ↑ blood loss
> - impaired RBC production
> - ↑ RBC destruction
```leaflet
id: leaflet-map
image: [[Pasted image 20240105220744.png]]
defaultZoom: 9
width: 80%
```


<mark class="red">MICROcytic</mark>::- **Iron Deficiency Anemia**<br>- **Thalassemia**<br>- **Sideroblastic** Anemia<br>- **Lead Poisoning**<br>- **Chronic inflammation**
<mark class="red">MACROcytic</mark>::<mark class="red">Megaloblastic</mark><br>- **Vitamin B12 deficiency**<br>- **Folate deficiency**<br><br><mark class="red">Nonmegaloblastic</mark><br>- **Alcoholism**<br>- **Liver disease**<br>- **Hemolytic** anemia
<mark class="red">NORMOcytic</mark>::- **Hereditary hemolytic anemia**<br>- **Immune hemolytic anemia**<br>- **AIHA**<br>- **Malaria**<br>- **Hypoproliferative**<br>- **Acute hemorrhage**<br>- **Hemoglobinopathies**<br>- **Systemic** disorders


## Microcytic Anemia
?
![[Hema (ASCPi)#^5xq6dz]]


> [!NOTE]
> - $ ALPHA THALASSEMIA  (normal (aa/aa))
> 	- Silent carrier (a+/a) (\_a/aa) - Heterozygous condition; only 1 gene is deleted
> 	- Alpha Thalassemia Minor - 2 genes are deleted
> 		- (a+/a+) (\_a/\_a) = Homozygous
> 		- (ao/a) (\_\_/aa) = Heterozygous
> 	- Hemoglobin H disease -  3 genes are deleted; Heterozygous;
> 		- (ao/a+) (\_\_/\_a)
> 		- Hgb H = (beta 4)
> 	- Bart's Hydrops Fetalis = 4 genes are deleted; Homozygous
> 		- (ao/ao) (\_\_/\_\_)
> 		- Bart's Hgb (gamma 4) -  incompatible w/ life
> - $ BETA THALASSEMIA
> 	- Bo/Bo (NO PRODUCTION of beta chain) or B+/B+ (marked decrease in production) = Homozygous/Major/Cooley's anemia; severe macrocytic hypochromic anemia
> 	- Bo/B+ or Bo/B or B+/B = Heterozygous/Minor; no B chains are produced; no to variable anemia

> [!NOTE] Lead Poisoning
> - similar findings w/ sideroblastic anemia
> - coarse basophilic stippling
> - inhibits enzymes in the hemoglobin synthesis pathway (Ferrochelatase & ALA synthase) ^qd13m5

## Macrocytic Anemia
?
> [!info] Nonmegaloblastic
> -  Alcoholism (direct damage to RBC precursors)
> - Liver dss (↑ RBC membrane lipids that accumulate in RBCs, increasing the surface area relative to volume)
> - Hemolytic anemia (stimulate EPO production, thus EARLY RELEASE of Reticulocyte from the bone marrow)
> 
> > [!important] NOTE (vs MEGALOBLASTIC)
> > - RBCs are round
> > - Polychromasia
> > - NO HYPERsegmented neutrophil
> > - NO other megaloblastic change ^e3p28l

[!NOTE]
?
Megaloblasts (large RBCs precursors w/ basophilic cytoplasm and fine particulate chromatin; NUCLEAR-CYTOPLASMIC ASYNCHRONY seen)

### CAUSES Of Folate and Vitamin B12 Deficiency
?
![[Hema (ASCPi)#^qk9x3t]]



### MANIFESTATIONS Of Folate and Vitamin B12 Deficiency
?
![[Hema (ASCPi)#^ja0442]]


## RBC Inclusions
?
![[Hema (ASCPi)#^bgxymc]]


<mark class="red">RNA</mark>::<mark class="red">Diffuse basophIlia</mark><br><br>Fine Basophilic Stippling
<mark class="red">Precipitated RNA</mark>::<mark class="red">Basophilic stippling</mark><br><br>coarse
<mark class="red">DNA (nuclear fragment)</mark>::<mark class="red">Howell-Jolly body</mark>
<mark class="red">Denatured hemoglobin</mark>::<mark class="red">Heinz body</mark>
<mark class="red">Iron</mark>::<mark class="red">Pappenheimer bodies</mark><br><br>(+) Prussian blue stain
<mark class="red">Remnant of mitotic spindle</mark>::<mark class="red">Cabot ring</mark>
Precipitate of <mark class="red">β-globin chains</mark> of hemoglobin::<mark class="red">Hb H</mark>

**Hemolytic anemia** <br>**After treatment for iron**, **vitamin B12**, or **folate deficiency**::<mark class="red">Diffuse basophIlia</mark><br><br>Fine Basophilic Stippling
**Lead poisoning** <br>**Thalassemia** <br>**Hemoglobinopathies** <br>**Megaloblastic anemia** <br>**Myelodysplastic syndrome**::<mark class="red">Basophilic stippling</mark><br><br>coarse
**Hyposplenism** <br>**Postsplenectomy** <br>**Megaloblastic anemia** <br>**Hemolytic anemia** <br>**Thalassemia** <br>**Myelodysplastic syndrome**::<mark class="red">Howell-Jolly body</mark>
**Glucose-6-phosphate dehydrogenase deficiency** <br>**Unstable hemoglobins** <br>**Oxidant drugs/chemicals**::<mark class="red">Heinz body</mark>
**Sideroblastic anemia** <br>**Hemoglobinopathies** <br>**Thalassemias** <br>**Megaloblastic anemia** <br>**Myelodysplastic syndrome**<br>**Hyposplenism** <br>**Post-splenectomy**::<mark class="red">Pappenheimer bodies</mark><br><br>(+) Prussian blue stain
**Megaloblastic anemia**<br>**Myelodysplastic syndromes**::<mark class="red">Cabot ring</mark>
**Hb H disease**::<mark class="red">Hb H</mark>

# RBC Anomalies
?
![[Hema (ASCPi)#^jzzn8f]]
![[Hema (ASCPi)#^6nxec3]]

**Hemolytic**, **megaloblastic**, **iron deficiency anemia**::<mark class="red">Anisocytosis</mark>
**Megaloblastic anemia** <br>**Myelodysplastic syndrome** <br>**Chronic liver disease** <br>**Bone marrow failure** <br>**Reticulocytosis**::<mark class="red">Macrocyte</mark>
**Megaloblastic anemia**::<mark class="red">Oval macrocyte</mark>
**Iron deficiency anemia** <br>**Anemia of chronic inflammation** <br>**Sideroblastic anemia** <br>**Thalassemia/Hb E** disease and trait::<mark class="red">Microcyte</mark>
**Severe anemia**; certain shapes helpful diagnostically::<mark class="red">Poikilocytosis</mark>
**Hereditary spherocytosis** <br>**Immune hemolytic anemia**<br>**Extensive burns (along with ==schistocytes==)**::<mark class="red">Spherocyte</mark>
**Hereditary elliptocytosis or ovalocytosis**<br>**Iron deficiency anemia** <br>**Thalassemia major** <br>**Myelophthisic anemias**::<mark class="red">Elliptocyte, ovalocyte</mark>

Abnormal variation in **RBC volume or diameter**::<mark class="red">Anisocytosis</mark>
Large RBC (**>8 µm** in diameter), **MCV >100 fL**::<mark class="red">Macrocyte</mark>
Large oval RBC::<mark class="red">Oval macrocyte</mark>
Small RBC (**<6 µm** in diameter), **MCV <80 fL**::<mark class="red">Microcyte</mark>
Abnormal variation in RBC **shape**::<mark class="red">Poikilocytosis</mark>
Small, round, dense RBC with **no central pallor**::<mark class="red">Spherocyte</mark>
Elliptical (**cigar-shaped**), oval (**egg-shaped**), RBC::<mark class="red">Elliptocyte, ovalocyte</mark>

RBC with **slit-like area** of central pallor <br>::<mark class="red">Stomatocyte</mark> ☺
Thin, dense, **elongated** RBC **pointed** at each end; may be **curved**::<mark class="red">Sickle cell</mark>
**Hexagonal** crystal of dense hemoglobin formed within the RBC membrane::<mark class="red">Hb C crystal</mark>
**Fingerlike or quartz-like** crystal of dense hemoglobin **protruding** from the RBC membrane::<mark class="red">Hb SC crystal</mark>
RBC with **hemoglobin concentrated in the center** and around the **periphery** resembling a target::<mark class="red">Target cell (codocyte)</mark>
**Fragmented** RBC due to **rupture in the peripheral circulation**::<mark class="red">Schistocyte (schizocyte)</mark>
RBC fragment in shape of a helmet::<mark class="red">Helmet cell (keratocyte)</mark>
RBC with **membrane folded over**::<mark class="red">Folded cell</mark>
Small, dense RBC with few **irregularly spaced projections** of varying length::<mark class="red">Acanthocyte (spur cell)</mark>  ☺
RBC with **blunt or pointed, short projections** that are usually **evenly spaced** over the surface of cell; present in all fields of blood film but in variable numbers per field\*::<mark class="red">Burr cell (echinocyte)</mark> ☺
RBC with a **single pointed extension** resembling a **teardrop** or **pear**::<mark class="red">Teardrop cell (dacrocyte)</mark>


**Hereditary stomatocytosis**<br>**Rh deficiency syndrome (<mark class="red">Rh null</mark>)**<br>**Acquired stomatocytosis (==liver disease==, ==alcoholism==)**::<mark class="red">Stomatocyte</mark> ☺
**Sickle cell anemia**<br>**Sickle cell–β-thalassemia**::<mark class="red">Sickle cell</mark>
**Hb C disease**::<mark class="red">Hb C crystal</mark>
**Hb SC disease**::<mark class="red">Hb SC crystal</mark>
**Liver disease** <br>**Hemoglobinopathies**<br>**Thalassemia**::<mark class="red">Target cell (codocyte)</mark>
**MICROangiopathic hemolytic anemia**\* (along with microspherocytes)<br>**MACROangiopathic hemolytic anemia**\**<br>**Extensive burns** (along with microspherocytes)::<mark class="red">Schistocyte (schizocyte)</mark>
Same as **schistocyte**::<mark class="red">Helmet cell (keratocyte)</mark>
**Hb C disease** <br>**Hb SC disease**::<mark class="red">Folded cell</mark>
**Severe liver disease (<mark class="red">spur cell anemia</mark>)**<br>**Neuroacanthocytosis (<mark class="red">abetalipoproteinemia</mark>, <mark class="red">McLeod syndrome (Kell null)</mark>)**::<mark class="red">Acanthocyte (spur cell)</mark>  ☺
**Uremia** (if not found, find Kidney failure) <br>**Pyruvate kinase deficiency**::<mark class="red">Burr cell (echinocyte)</mark> ☺
**Primary myelofibrosis** <br>**Myelophthisic anemia**<br>**Thalassemia** <br>**Megaloblastic anemia**<br><br><mark class="red">3Ms</mark>::<mark class="red">Teardrop cell (dacrocyte)</mark>


![[Pasted image 20240429160540.png]]::<mark class="red">Normal peripheral smear</mark>
![[Pasted image 20240429160601.png]]::<mark class="red">Macrocytes</mark>
![[Pasted image 20240429160629.png]]::<mark class="red">Hereditary elliptocytosis</mark>
![[Pasted image 20240429160802.png]]::<mark class="red">Schistocytes</mark>
![[Pasted image 20240429160811.png]]::<mark class="red">Echinocytes</mark>
![[Pasted image 20240429160823.png]]::<mark class="red">Microcytic hypochromic</mark>
![[Pasted image 20240429160844.png]]::<mark class="red">Hereditary spherocytosis</mark>
![[Pasted image 20240429161054.png]]::<mark class="red">Target cells</mark>
![[Pasted image 20240429161112.png]]::<mark class="red">Acanthocytes</mark>
![[Pasted image 20240429161124.png]]::<mark class="red">Artifact</mark>


Erythrocytes appear as **circular, homogeneous disks** of nearly uniform size, ranging from **6–8 µm** in diameter, with central pallor not exceeding more than one third of the cell. On average, the red cells are **approximately the same size as the nucleus of a <br>==small lymphocyte==** (<mark class="red">500x</mark>).::<mark class="red">Normal peripheral smear</mark>
Red cells are larger and thicker, stain deeply, and **lack central pallor** (<mark class="red">500x</mark>).::<mark class="red">Macrocytes</mark>
Most cells are **elliptocytes**. They are seen in a normal person’s blood, but usually account for **less than 10% of cells**. They are also common in <mark class="red">**iron deficiency anemia**, **myelofibrosis**, **megaloblastic anemia**, and **sickle cell anemia** </mark>(<mark class="red">1000x</mark>).::<mark class="red">Hereditary elliptocytosis</mark>
Presence of **cell fragments** is indicative of **hemolysis**. Schistocytes can be seen in several conditions, including <mark class="red">**microangiopathic hemolytic anemia**, **megaloblastic anemia**, **burns**, and **disseminated intravascular coagulation** </mark>(<mark class="red">500x</mark>).::<mark class="red">Schistocytes</mark>
Regularly contracted cells with **sharp ends**; may occur as an artifact during **film preparation** or as the result of **hyperosmolarity** or **decreased adenosine triphosphate** due to several causes (<mark class="red">1000x</mark>).::<mark class="red">Echinocytes</mark>
Red cells in <mark class="red">**iron deficiency anemia**</mark>. Red cells are hypochromic—the amount of hemoglobin per cell is decreased, and the **central pale area becomes larger (==more than one third==)** (<mark class="red">500x</mark>).::<mark class="red">Microcytic hypochromic</mark>
Spherocytes are **nearly perfectly round** in shape, **smaller** than normal red cells, and lack central pallor (**hyperchromic**) (<mark class="red">1000x</mark>).::<mark class="red">Hereditary spherocytosis</mark>
Red cells with **thin membrane**, peripheral rim of hemoglobin (Hb), and dark, central, Hb-containing area. They are frequently seen in <mark class="red">**Hb C disease**, in **hypochromic anemia**, and in **liver disease**</mark> (<mark class="red">1000x</mark>).::<mark class="red">Target cells</mark>
**Irregularly spiculate**d cells with **bulbous and rounded end**s, frequently seen in <mark class="red">**ABETALIPOPROTEINEMIA**</mark> or certain cases of **liver disease** (<mark class="red">1000x</mark>).::<mark class="red">Acanthocytes</mark>
**Tiny pits or bubbles** in the red cells. They can be caused by a small amount of **water** contaminating the Wright’s stain or by **insufficient slide drying** (<mark class="red">500x</mark>).<br><br><mark class="red">Moth-eaten appearance</mark>::<mark class="red">Artifact</mark>

[!NOTE] Hereditary ELLIPTOcytosis
?
- normal pbs (<10% elliptocyte)
- autosomal DOMINANT
- diagnosed when >25% elliptocytes
- Forms
	- Common (elliptocytes, asymptomatic to severe)
	- Spherocytic HE (spherocytes + elliptocytes)
	- Stomatocytic HE (aka Southeast Asian Ovalocytosis; resistance to P. vivax)
- Defect of Hereditary ELLIPTOcytosis (Spectrin & Band 4.1)
- (Hereditary PYROpoikilocytosis) Severe subtype of HE; autosomal RECESSIVE

[!NOTE] Hereditary SPHEROcytosis
?
- Defects of Hereditary SPHEROcytosis (Ankyrin, Band 3, Spectrin)
- ↑ MCHC (50% of the cases)
- spherocyte & polychromasia
- ↑ osmotic fragility
- negative for DAT
- ↓ EMA (eosin-5-maleimide) binding test, aka Band 3 reduction test

# LEUKOCYTE DISORDERS


## Summary of Leukocyte Disorders

<mark class="red">NON-malignant Granulocytic</mark> Disorders::<mark class="red">QUANtitative</mark><br>1. **Physiologic PSEUDOneutrophilia** (Neutrophilia = >7500/uL)<br>2. **Pathologic Neutrophilia** (toxic changes (granulations, vacuolations, Dohle bodies))<br>3. **Neutrophilic Leukemoid Reaction** (Left shift; ↑ LAP score)<br>4. **Leukoerythroblastic Reaction**<br><br><mark class="red">QUALitative</mark><br>5. <mark class="red">**Functional Disorders**</mark><br>   - **Chronic Granulomatous Disease**<br>   - **Chediak-Higashi Syndrome**<br>6. <mark class="red">**Nuclear Abnormalities**</mark><br>   - **Hypersegmentation** (Megaloblastic Anemia)<br>   - **Hyposegmentation (==Pelger-Huet== and ==Pseudo Pelger-Huet Anomaly==)** -  lobulations  <2<br>7. <mark class="red">**Inherited Cytoplasmic Anomalies**</mark><br>   - **May-Hegglin Anomaly**<br>   - **Alder-Reily Anomaly**
<mark class="red">Monocytic</mark> Disorders::1. **Gaucher’s disease** (glucocerebrosidase deficiency; crumpled tissue paper appearance)<br>2. **Niemann-Pick disease** )sphingomyelinase deficiency; foamy appearance)
<mark class="red">Non-malignant Lymphocytosis</mark> Associated with **Viral Infections**::1. **Infectious Mononucleosis** (EBV; reactive T lymphocytes; heterophile Ab (+))<br>2. **Cytomegalovirus** (similar to IM; most common TRANSPLACENTALLY transmitted infection; NO reactive lymphocytes; heterophile Ab (-))<br>3. **Infectious Lymphocytosis** (Adenovirus, Coxsackie A; no reactive lymphocytes)
<mark class="red">Malignant Leukocytic</mark> Disorders::1. **Acute Lymphoproliferative Disorders**<br>2. **Acute Myeloproliferative Disorders**<br><br>3. <mark class="red">**Chronic Leukemias**</mark><br>   - **Chronic Myelogenous Leukemia**<br>   - **Essential Thrombocythemia**<br>   - **Polycythemia Vera**<br>   - **Chronic Idiopathic Myelofibrosis**<br>   - **Chronic Lymphocytic Leukemia**<br>   - **Hairy Cell Leukemia**<br>   - **Prolymphocytic Leukemia**<br>4. <mark class="red">**Other Lymphoid Malignancies**</mark><br>   - **Multiple Myeloma**<br>   - **Waldenstrom’s Macroglobulinemia**<br>   - **Hodgkin's Lymphoma**<br>   - **Non-Hodgkin's Lymphoma**<br>   - **Mycosis Fungoides**<br><br>5. **Myelodysplastic Syndromes**


- ineffective intracellular destruction of ingested organisms<br>- defect in the respiratory burst (used to kill the organism)<br>- MORPHOlogically normal, FUNCTIONALLY ABnormal<br>- deficiency in NADPH oxidase (important for WBC to mount the respiratory burst)::<mark class="red">Chronic Granulomatous Disease</mark>
- abnormal fusion of primary & secondary granules<br>- due to a mutation in the lysosomal trafficking regulatory gene (CHS1 / LYST)<br>- gigantic granules that are peroxidase (+)<br>- MORPHOlogically ABnormal, FUNCTIONALLY ABnormal::<mark class="red">Chediak-Higashi Syndrome</mark>



- large, crystalline, dohle-like inclusions<br>- giant platelets, ↓ PLT count (giants no longer counted as PLT), bleeding<br>- MYH9 gene mutation::<mark class="red">May-Hegglin Anomaly</mark>
- large azurophilic granules which contains DEGRADED MUCOPOLYSACCHARIDES<br>- Hunter, Hurler, San Filippo syndrome::<mark class="red">Alder-Reily Anomaly</mark>




- cellular morphology<br>- cytochemical staining<br>- >30% blasts BM & PBS::<mark class="red">FAB</mark><br>
- standard for diagnosis<br>- immunologic probes<br>- cytogenetics<br>- molecular abnormalities<br>- clinical syndrome<br>- >20% blasts BM & PBS::<mark class="red">WHO</mark>



 


![[Pasted image 20240429170247.png]]::A <mark class="red">neutrophil with toxic granulation</mark> is pictured, along with two bands. **Basophilic inclusions (==Döhle bodies==)** are present as well. (<mark class="red">x1000</mark>)
![[Pasted image 20240429170257.png]]::The <mark class="red">Alder-Reilly anomaly</mark> may be found in **healthy** individuals or in those **mucopolysaccharidoses**, in which granules are metachromatic (<mark class="red">x1000</mark>).
![[Pasted image 20240429170313.png]]::<mark class="red">Chédiak-Higashi</mark> neutrophils and lymphocytes with **large granules** (<mark class="red">x1000</mark>).
![[Pasted image 20240429170324.png]]::<mark class="red">Auer rods</mark> vary from prominent, as in this cell, to thin and delicate.
![[Pasted image 20240429170334.png]]::An **abnormal macrophage** in <mark class="red">Gaucher’s disease</mark> (<mark class="red">x1000</mark>)
![[Pasted image 20240429170351.png]]::<mark class="red">May-Hegglin anomaly</mark>, showing **Döhle-like inclusions** (<mark class="red">x1000</mark>).
![[Pasted image 20240429170401.png]]::<mark class="red">Inherited Pelger-Huët anomaly</mark> (<mark class="red">x1000</mark>).
![[Pasted image 20240429170412.png]]::<mark class="red">Infectious mononucleosis</mark>, showing a **large activated lymphoid cell** in the blood (<mark class="red">x1000</mark>).
![[Pasted image 20240429170422.png]]::<mark class="red">Sézary cell</mark> in the blood, along with a neutrophil (<mark class="red">x1000</mark>).
![[Pasted image 20240429170434.png]]::An **abnormal macrophage** in <mark class="red">Niemann-Pick disease</mark> (<mark class="red">x1000</mark>)

## Acute MYELOID Leukemia
?
- AML with **recurrent genetic abnormalities**
- AML with **myelodysplasia related changes**
- **Therapy-related myeloid neoplasms**
- AML, not otherwise specified

[!NOTE]
?
- represents MOST leukemia in ADULTS & INFANTS
- ↑ WBC ct (due to BLASTS); variable (depending on the type of leukemia)
- NORMOcytic, NORMOchromic
- ↓ PLT ct

[!NOTE]
?
q = long arm
p = short arm
1st digit = region
2nd digit = band
1st digit after decimal = subband
q22 (long arm of region 2, band 2)
q22.1 (long arm of region 2, band 2, subband 1)

Genetic Abnormality
?
![[Hema (ASCPi)#^ms86kr]]


**MPO**, CD **34**, CD **13**, **HLA-DR** positive; sometimes CD **56** & CD **19** positive::<mark class="red">t(8;22)</mark><br><br>(q22;q22.1)
CD **34**, CD **13**, CD **33**, CD **14**, CD **2**, CD **11b**, CD **11c**, CD **64**, **lysozyme** positive::<mark class="red">in(16)</mark><br><br>(p13.1;q22)<br>or<br>t(16;16)
CD **33**, CD **13** positive; CD **15**, **HLA-DR** both WEAKLY positive; CD **2**, CD **34** may be positive in microgranular variant.::<mark class="red">t(15;17)</mark><br><br>(q22;q12)
CD **33**, CD **64**, CD **4**, **HLA-DR**, CD **11b**, CD **14**, **lysozyme** positive::<mark class="red">t(9;11)</mark><br><br>(p21.3;q23.3)
**MPO**, CD **13**, CD **33**, CD **38**, **HLA-DR** CONSISTENTLY positive; CD **117**, CD **34**, CD **15** may be positive; CD **64** positive in some cases.::<mark class="red">t(6;9)</mark><br><br>(q23;q34.1)
CD **13**, CD **33**, **HLA-DR**, CD **34**, CD **38** positive; subsets may be CD **41**, CD **61** positive::<mark class="red">inv(3)</mark><br><br>t(3,3)
CD **41**, CD **42b**, CD **61**, CD **13**, CD **33** positive::<mark class="red">t(1;22)</mark><br><br>(p13.3;q13.3)

## AML not otherwise specified (NOS)
?
![[Hema (ASCPi)#^8r4n2x]]


CD **34**, **HLA-DR**, CD **13**, CD **33**, CD **117**::M0<br><br><mark class="red">AML w/ minimal differentiation</mark>
CD **13**, CD **33**, CD **34**, CD **117**, **HLA-DR** positive::M1<br><br><mark class="red">AML w/o maturation</mark>
CD **13**, CD **33**, CD **117**, **HLA-DR**, CD **15** positive; VARIABLE expression of HLA-DR, CD **34**::M2<br><br><mark class="red">AML w/ maturation</mark>
CD **13**, CD **33**, CD **14**, CD **4**, CD **11b**, CD **64**, **lysozyme** all positive::M4<br><br><mark class="red">Acute MyeloMONOcytic Leukemia</mark>
CD **13**, CD **33**, CD **117** variable; CD **14**, CD **4**, CD **11b**, CD **64**, **lysozyme** positive::<mark class="red">Acute MonoBLASTic L</mark> (M5a)<br><br><mark class="red">Acute MonoCYTIC L</mark> (M5b)
**Glycophorin A (CD 235)**: CD<mark class="red">34</mark>, CD<mark class="red">71</mark> positive::M6<br><br><mark class="red">Acute Erythroid Leukemia</mark>
CD<mark class="red">41</mark> and/or CD<mark class="red">61</mark>, CD **13**, CD **33** positive::M7<br><br><mark class="red">Acute Megakaryoblastic Leukemia</mark>
CD **13**, CD **33**, CD **34**, **HLA-DR** positive; CD **117** NEGATIVE::<mark class="red">Acute Basophilic Leukemia</mark>
CD **13**, CD **33**, CD **117** positive; CD **41**, CD **61** VARIABLE::<mark class="red">Acute Panmyelosis w/ Myelofibrosis</mark>

[!NOTE]
?
CD41 & 61 (glycoproteins found on the surface of platelets)
CD41 (main component Gp2b3A)
CD61 (complexes w/ 41 to form Gp2b3a)

[!NOTE] MPO (Myeloperoxidase)
?
 present in the granules of myeloid series (granulocytes, monocytes)

[!NOTE] NSE (Non-specific esterase) -  <mark class="red">monocytes</mark>
?
- alpha naphthyl ACETATE
- alpha naphthyl BUTYRATE ^m3yd7a

[!NOTE] SE (Specific esterase) - <mark class="red">granulocytes</mark>
?
- Naphthol AS-D Choloroacetate esterase

## Myelodysplastic Syndromes
?
Myeloid neoplasms characterized by **ineffective hematopoiesis** that displays as **cytopenias**, **dyspoiesis** in at least 1 of the major myeloid lineages, and **increased risk of developing into AML**.
> [!NOTE] Title
> usually seen in OLDER adults
> seen in YOUNG adults due to secondary (chemotherapy, exposure to radiation, benzene, inherited bone marrow failure eg. Fanconi Anemia)

[!NOTE] Lab Findings
- ?
- Hypercellular BM
- <20% blasts
- many dysplastic changes affecting each cell lineage both in PBS & BM 

[!NOTE] Dysplastic changes (Myeloid Lineage)
?
- <mark class="red">DysERYTHROpoeisis (RBC)</mark>
	- Anisocytosis, Poikilocytosis
	- Basophilic stipplings
	- Irregular cytoplasmic staining
	- Ringed sideroblasts
- <mark class="red">DysGRANULOpoeisis (WBC)</mark>
	- Hypogranulation/abnormal granulation
	- Pseudo-Pelger Huet Anomaly
	- Hypersegmentation
	- Auer rods
- <mark class="red">DysMEGAKARYOCYTOpoeisis (PLT)</mark>
	- MICROmegakaryocytes
	- HYPOgranulation, large abnormal granules
	- Giant platelets
	- Functional abnormalities
- #mcl/list-grid 

### WHO CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES
?
> [!NOTE] WHO Scheme (basis of classification for MS)
> - degree of cytopenia & dysplasia
> - CYTOPENIA
> 	- Hgb <10g/dL (<100g/L)
> 	- PLT ct <100 x 103/uL (100 x 109/L)
> 	- Absolute Neutrophil ct <1800/uL (<1.8x109/L)
> 	- Peripheral blood monocytes <1000/uL (<1.0 x109/L)
> - percentage of blasts in the peripheral blood & BM
> - percentage of RINGED SIDEROBLASTS in the BM
![[Hema (ASCPi)#^z1xt9f]]



## MDS, UNCLASSIFIED
![[Hema (ASCPi)#^asngka]]


## Myeloproliferative Neoplasms
?
- Group of closely related **malignant** disorders that **result from AUTONOMOUS CLONAL PROLIFERATION of hematopoietic stem cells**.
- Although characterized by abnormal proliferation of **all myeloid** lineages, **1 cell line typically more prominently involved**.
> [!NOTE]
> usually affecting middle-aged or older adults

### LABORATORY FINDINGS IN SELECTED MYELOPROLIFERATIVE NEOPLASMS
?
![[Hema (ASCPi)#^5pc695]]


[!NOTE] CML cytogenetic anomaly
?
- t(q9;q22)
- 9 (ABL gene)
- 22 (BCR gene)

[!NOTE] <mark class="red">Philadelphia chromosome</mark>
?
-  changed chromosome <mark class="red">22</mark> (fusion of BCR & ABL gene)
- ![[Pasted image 20240509131620.png]]

[!NOTE] CML stages
?
- Dormant (<10% blasts)
- Accelerated (10 - 19%)
- Blast crises (>20%)

# LABORATORY PROCEDURES

Improved Neubauer Ruling on the Hemocytometer<br><br>![[Pasted image 20240430153806.png]]::- <mark class="red">WBCs</mark> are usually counted in A, B, C and D. <br>(1:20 = 4 corner squares; 1:100 = all 9 squares)<br>(Volume = 1mm x 1mm x 0.1 mm = 0.1mm 3/uL)<br><br>- <mark class="red">RBCs</mark> are usually counted in the **blue**-colored small squares.<br>(1:100 or 1:200 dilution)<br>(Volume = 0.2 mm x 0.2 mm x 0.1 mm = 0.004 mm3/uL)<br><br>- <mark class="red">Platelets</mark> are usually counted in the **blue**- and **green**-colored small squares.<br>(1:100 dilution)<br>(Volume = 1mm x 1mm x 0.1mm = 0.1 mm3/uL)<br>(Phase Contrast microscope)
General Formula for Cell Count Using the Neubauer Ruling::![[Pasted image 20240430154119.png]]<br><br>total vol in chamber counted = (# square counted) x (volume of 1 square)
<mark class="red">Corrected Wbc Count</mark><br><br>if at least 5 nRBCs are seen::100-cell differential<br>![[Pasted image 20240430154146.png]]<br><br>50-cell differential<br>![[Pasted image 20240430154205.png]]
<mark class="red">Electronic Impedance Counters</mark>::Particles (most often cells) are forced to flow through small openings i.e., apertures, between two electrodes in an ionic solution. As each cell passes thru the aperture, the **electrical resistance** between the two electrodes increases, recorded as **voltage pulses**, because **cells are poor conductors of electricity.**<br><br><mark class="red"># pulse = # of cells</mark><br><mark class="red">amplitude = cell size</mark><br><br>**<mark class="red">WBC count</mark> (in WBC aperture)**. Particles larger than 35fL are counted as WBC.<br>- <mark class="red">**small mononuclear** or **lymphocytes**</mark> = **35 – 90 fL**<br>- <mark class="red">**large mononuclear** or **monocytes**</mark> = **90 – 160 fL**<br>- <mark class="red">**neutrophils** and **other granulocytes**</mark> = **160 – 450 fL**<br><br>**<mark class="red">RBC count</mark> (in RBC aperture)**. Particles in the size range of **36 – 360 fL** are counted as RBCs.<br><br>**<mark class="red">Platelet count</mark> (in RBC aperture)**. Particles in the size range of **2 – 20 fL** are counted as platelets
SCHEMA OF IMPEDANCE INSTRUMENT::![[Pasted image 20240430154542.png]]


[!NOTE] Basic principles/methods used in automated cell counting
?
Electrical Impedance
Optical (Light) Scatter

[!NOTE]
?
Forward scatter (cell size)
Side scatter (90°), Orthogonal (cellular granularity/complexity)

## RED BLOOD CELL INDICES

Indicates **average size** of RBCs.::<mark class="red">MCV</mark><br><br>NV: **80 - 100 fL**
Indicates **average weight of hemoglobin** per RBC.<br><br>NOT USED for the morphological classification of anemia::<mark class="red">MCH</mark><br><br>NV: **26 - 32 pg**
Represents **average concentration of hemoglobin per 100mL** of packed RBCs (pRBCs).<br><br>if 36 - 38 g/dL (check SPHEROCYTES)<br>if >38 g/dL (check ERRORS in Hgb det.)::<mark class="red">MCHC</mark><br><br>NV: **32 - 36 g/dL**


## HISTOGRAMS
?
A histogram utilizes **impedance technology**. It is a representation of **cell number versus one measured property**, usually cell size.

![[Pasted image 20240430155516.png]]::<mark class="red">WBC </mark> Histogram
![[Pasted image 20240430155523.png]]::<mark class="red">RBC</mark> Histogram
![[Pasted image 20240430155532.png]]::<mark class="red">Platelet</mark> Histogram

- **35 to 450 fL** is the reference size range for WBCs<br>  - 1st peak (<mark class="red">Lymphocytes</mark>; 35 - 90 fL)<br>  - 2nd peak (<mark class="red">Monocytes</mark>; 90 - 160 fL)<br>  - 3rd peak (<mark class="red">Granulocytes</mark>; 160 - 450 fL)::<mark class="red">WBC </mark> Histogram
- **36 fL and above** is the reference size range for RBCskk<br>  - A normal RBC histogram will show a **SINGLE peak between 70 to 110 fL** that will correlate with MCV::<mark class="red">RBC</mark> Histogram
- **2 to 20 fL** is the reference size range for platelets<br><br>occur BEFORE the start of RBC histogram::<mark class="red">Platelet</mark> Histogram

### ABNORMAL WBC HISTOGRAMS

nRBCs; giant or clumped PLT::Population <mark class="red">before 35fL</mark>
reactive lymphocytes/ blast cells::Peak overlap <mark class="red">at 90fL</mark>
↑ bands (other immature granulocyte forms)::Peak overlap <mark class="red">at 160fL</mark>
HIGH granulocyte count::Population <mark class="red">after 450 fL</mark>

### ABNORMAL RBC HISTOGRAMS

dimorphic RBC population (1. **2 deficiencies**; 2. **post-transfusion/post-therapy**)::<mark class="red">Two peaks</mark>
↑ RDW; Anisocytosis (variation in cell size)::<mark class="red">Increase curve width</mark>
↑ MCV = MACROcytes::<mark class="red">Shift to the RIGHT</mark><br><br>in relation to the peak ![[Pasted image 20240509143110.png]]
↓ MCV = MICROcytes::<mark class="red">Shift to the LEFT</mark>

### Conditions That Cause Interferences On MOST HEMATOLOGY ANALYZERS
?
![[Hema (ASCPi)#^ix663k]]



## RETICULOCYTE COUNT
?
> [!NOTE]
> INDICATOR of BM response 
- provides a measure of erythropoiesis and often used to assess the **bone marrow's response** to anemia.
- Manual methods use **supravital stains** such as <mark class="red">new methylene blue</mark> or <mark class="red">brilliant cresyl blue</mark>.

![[Pasted image 20240430155745.png]]::Appearance of reticulocytes under <mark class="red">Wright stain</mark>.<br>Polychromatic macrocytes
![[Pasted image 20240430155755.png]]::Appearance of reticulocytes after <mark class="red">supravital staining</mark> (black arrows). Heinz bodies may also be stained (red arrows)
<mark class="red">RELATIVE</mark> Reticulocyte Count<br>::uses a MILLER DISC<br>NV: 0.5 - 1.5%
<mark class="red">ABSOLUTE</mark> Reticulocyte Count<br>::actual # of retics per L of whole blood<br>NV: 25 - 75 x 109/L
<mark class="red">CORRECTED</mark> Reticulocyte Count::spx have ↑HCT = falsely HIGH retic ct<br>NV: 35% = 2 - 3%; <25% = 3 - 5%
<mark class="red">Reticulocyte Production Index</mark>::Maturation Time<br>36-45 = 1.0<br>26-35 = 1.5<br>16-25 = 2.0<br>≤ 15 = 3.0<br><br>SHIFT reticulocytes (prematurely released into the circulation)<br><br>>3% (adequate response)<br><2% (INadequate)



## ERYTHROCYTE SEDIMENTATION RATE
?
- **NONspecific** measurement used to detect and monitor an **inflammatory response**
- **settling of RBCs** at the bottom of a tube upon standing **undisturbed for 1 hour**
- distance in **milliliters** that the RBCs fall in 1 hour

## FACTORS AFFECTING ESR RESULT
?
> [!NOTE]
> very important in ESR (<mark class="red">ROULEAUX Formation</mark>)
> NO Rouleaux = ↓ ESR
![[Hema (ASCPi)#^gapozd]]



## LAP STAINING TECHNIQUE
?
> [!NOTE]
> differentiates CML vs LR
- stains the <mark class="red">alkaline phosphatase</mark> present in **neutrophils** (mature forms only) and to a small degree, in certain **B lymphocytes**
- this is helpful in the differentiation of <mark class="red">chronic myelogenous</mark> from <mark class="red">leukemoid reaction</mark> and <mark class="red">polycythemia vera</mark>.
- the specimen of choice is <mark class="red">fresh capillary blood</mark>, but alternatively blood may be collected using <mark class="red">heparin</mark> as anticoagulant.
- & <mark class="red">Kaplow count</mark> is performed where a total of **100 neutrophils** are scored from 0 (negative) to 4 (strongly positive) based upon the intensity of staining reaction.

EXAMPLE




## CONDITIONS ASSOCIATED WITH LAP SCORING

<mark class="red">INCREASED</mark>::- **<mark class="red">Leukemoid reaction</mark>**<br>- **<mark class="red">Polycythemia vera</mark>**<br>- **3rd Trimester** of pregnancy<br>- **Infection (Neutrophilia)**<br>- **Multiple myeloma**<br>- **Corticosteroid therapy**<br>- **Myelosclerosis**<br>- **Obstructive jaundice**
<mark class="red">DECREASED</mark>::- **<mark class="red">Chronic myelogenous leukemia</mark>**<br>- **Paroxysmal nocturnal hemoglobinuria**<br>- **Sickle cell anemia**<br>- **Sideroblastic anemia**<br>- **Hereditary hypophosphatasemia**<br>- **Marked eosinophilia**<br>- **Rarely** in normal people
<mark class="red">NORMAL</mark>::- **Untreated hemolytic anemia**<br>- **Lymphosarcoma**<br>- **Viral hepatitis**<br>- **Secondary polycythemia**


## Immunophenotyping
?
- Valuable tool in **diagnosing** hematology malignancy
- Used **MONOclonal antibodies** to help subclassify leukemia and define other abnormalities
- **Acute MYELOID Leukemia** (refer to AML table)
- ~ **Acute LYMPHOBLASTIC Leukemia**
1. B cell (immunologic subgroups define by immunophenotype)
	- Early precursor (**pro-B** cell) B cell ALL: CD<mark class="red">34</mark> (most significant), CD<mark class="red">19</mark>, <mark class="red">TdT</mark>, <mark class="red">HLA-DR</mark>
	- **Intermediate pre-B** cell ALL: CD<mark class="red">10</mark> (most significant), CD<mark class="red">19</mark>, <mark class="red">HLA-DR</mark>, TdT, CD<mark class="red">34</mark> (sometimes)
	- Pre-B cell ALL: CD<mark class="red">19</mark>, <mark class="red">cIg</mark>, <mark class="red">HLA-DR</mark>, <mark class="red">TdT</mark>, CD<mark class="red">22</mark>, CD<mark class="red">10</mark> (sometimes)
2. T cell: CD<mark class="red">2</mark>, CD<mark class="red">3</mark>, CD<mark class="red">4</mark>, CD<mark class="red">5</mark>, CD<mark class="red">7</mark>, CD<mark class="red">8</mark>, <mark class="red">TdT</mark>
3. Selected lymphomas

### IMMUNOPHENOTYPE OF SELECTED MATURE B-CELL NEOPLASMS
?
![[Hema (ASCPi)#^f88016]]
